Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter
2026-08-10 17:04:29Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter business-standard.com...
Read MoreAstraZeneca Pharma India Q1 profit drops to 37.93 crore
2026-08-10 15:06:23AstraZeneca Pharma India Q1 profit drops to 37.93 crore BusinessLine...
Read MoreAstraZeneca Pharma India Q1 results: Profit drops 32% to 37.93 crore
2026-08-10 14:52:34AstraZeneca Pharma India Q1 results: Profit drops 32% to 37.93 crore business-standard.com...
Read MoreAstraZeneca Shares Fall on Deal Talks With Bristol-Myers
2026-08-03 13:38:23AstraZeneca Shares Fall on Deal Talks With Bristol-Myers BloombergAstraZeneca slides after report of Bristol Myers merger talks leaves analysts \'perplexed\' CNBCAn AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it odd MarketWatchEditors Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea Fierce PharmaBiotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? Yahoo Finance...
Read MoreAstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks
2026-08-03 13:36:00AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks WSJ...
Read MoreAstraZeneca Pharma India CFO Bhavana Agrawal resigns
2026-07-21 11:31:11AstraZeneca Pharma India CFO Bhavana Agrawal resigns Business Standard...
Read MoreAstraZeneca Pharma India announces resignation of CFO
2026-07-21 10:17:16AstraZeneca Pharma India announces resignation of CFO Business Standard...
Read MoreIntimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
08-Aug-2026 | Source : BSEPlease find the enclosed letter of the Company as per the captioned subject for your reference.
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday August 10 2026
04-Aug-2026 | Source : BSEAstrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Monday August 10 2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30 2026. We also confirm that the Trading Window remains closed for all Designated Persons from June 16 2026 to August 12 2026 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
30-Jul-2026 | Source : BSEPlease find the enclosed document of the Company in relation to the captioned subject for your reference.
Corporate Actions
No Upcoming Board Meetings
Astrazeneca Pharma India Ltd has declared 1800% dividend, ex-date: 31 Jul 26
Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06
No Bonus history available
No Rights history available